verubecestat (MK-8931) / Merck (MSD) 
Welcome,         Profile    Billing    Logout  
 14 Diseases   1 Trial   1 Trial   211 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
verubecestat (MK-8931) / Merck (MSD)
ACTRN12611000568910: A Single and Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics SCH 900931 in Healthy Adult Japanese Subjects.

Not yet recruiting
N/A
24
 
Schering-Plough Research Institute, a Division of Schering Corporation, a Subsidiary of Merck & Co., Inc, Schering-Plough Research Institute, a Division of Schering Corporation, a Subsidiary of Merck & Co., Inc
Healthy volunteers
 
 

Download Options